Pfizer COVID-19 Vaccine Sales Tumble
Digest more
Pfizer Raises Profit Outlook
Digest more
Despite a drop in COVID product demand, Pfizer Inc (PFE) surpasses EPS expectations and advances key strategic initiatives.
Pfizer and Novo Nordisk's fight for obesity drug developer Metsera ratcheted up on Tuesday, as both companies submitted ...
Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...
Due to the litigation Pfizer filed Friday and Monday against Metsera, Novo Nordisk and the biotech’s lead shareholder, CEO ...
Pfizer has increased its annual profit forecast and reported higher-than-expected profits for the third quarter amid a legal ...
CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...
Experts are still encouraging people to take the drug if prescribed. When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback